Outlook Therapeutics, Inc. (OTLK)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

17

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
29-Mar-24 10:39 AM View:	28-Mar-24 Purchase $22.24K	Haddadin Yezan Munther Director		Outlook Therapeutics, Inc. - OTLK	59% 3.17K to 5.05K	0	0	--	--	Show Txns Hide Txns

11-Mar-24 4:43 PM View:	07-Mar-24 Private Purchase $26.24K	Evanson Jeff Chief Commercial Officer		Outlook Therapeutics, Inc. - OTLK	8% 745.98K to 808.46K	0	0	--	--	Show Txns Hide Txns

20-Mar-24 5:20 PM View:	18-Mar-24 Grant 0	Sukhtian Ghiath M. Director 10% Owner		Outlook Therapeutics, Inc. - OTLK	66% 3.5M to 5.81M	0	0	--	--	Show Txns Hide Txns

17-Apr-24 8:21 PM View:	15-Apr-24 Purchase 0	Syntone Ventures LLC 10% Owner		Outlook Therapeutics, Inc. - OTLK	72% 991.15K to 1.71M	0	0	--	--	Show Txns Hide Txns

30-Sep-24 4:53 PM View:	26-Sep-24 Purchase $28.45K	Kenyon Lawrence A CHIEF FINANCIAL OFFICER Director		Outlook Therapeutics, Inc. - OTLK	529% 0.95K to 5.95K	0	0	--	--	Show Txns Hide Txns